The following government grants in the FederalGrants.com database contain the term housing in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trials Not Allowed) |
93.351 |
PAR-21-090 |
| NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed) |
93.121 |
PAR-21-084 |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) |
93.394 |
RFA-CA-21-010 |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) |
93.394 |
RFA-CA-21-011 |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) |
93.394 |
RFA-CA-21-007 |
| Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required) |
93.847 |
PAR-20-309 |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) |
93.394 |
RFA-CA-21-012 |
| Expanding the Opioids System Model to more comprehensively incorporate fentanyl, stimulants use, polysubstance use and associated outcomes. |
93.103 |
FOR-FD-20-029 |
| Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) |
93.394 |
RFA-CA-21-008 |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional) |
93.394 |
RFA-CA-21-009 |
| Dermal Physiologically-Based Pharmacokinetic (PBPK) Models Accounting for the Absorption and Evaporation of Vehicle/Co-Solvent Following the Application of Generic Dermatological Products |
93.103 |
FOR-FD-20-027 |
| Small Vessel VCID Biomarker Validation Consortium Sites (U01)(Clinical Trials Not Allowed) |
93.853, 93.866 |
RFA-NS-21-005 |
| Small Vessel VCID Biomarkers Validation Consortium Coordinating Center (U24 Clinical Trial Not Allowed) |
93.853, 93.866 |
RFA-NS-21-004 |
| Reconfiguration of GenitoUrinary Development Molecular Anatomy Project (GUDMAP) /(Re)Building A Kidney (RBK) Data Hub (U24 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-20-014 |
| Quantify the expression of metabolizing enzymes and transporter proteins in lung, eye and skin tissue in relevant animal models and humans |
93.103 |
FOR-FD-20-025 |
| Impulse Oscillometry Endpoint Sensitivity to Regional Lung Function Changes using Computational Fluid Dynamics (CFD) |
93.103 |
FOR-FD-20-028 |
| Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) |
93.121, 93.393, 93.396, 93.846, 93.847, 93.853, 93.866 |
PAR-21-069 |
| Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) |
93.121, 93.242, 93.393, 93.396, 93.846, 93.847, 93.853, 93.866 |
PAR-21-068 |
| GenitoUrinary Development Molecular Anatomy Project (GUDMAP) - Atlas Projects (U01 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-20-013 |
| Preventing Violence Affecting Young Lives (PREVAYL) |
93.136 |
CDC-RFA-CE21-2104 |
| Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
93.394 |
RFA-CA-21-006 |
| Contraceptive Development Research Centers Program (P50 Clinical Trial Optional) |
93.865 |
RFA-HD-22-003 |
| Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32 - Clinical Trial Not Allowed) |
93.859 |
PAR-21-026 |
| Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional) |
93.853 |
PAR-21-058 |
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
93.394 |
RFA-CA-21-004 |
| Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) |
93.394 |
RFA-CA-21-005 |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) |
93.394 |
RFA-CA-21-003 |
| Initiative for Maximizing Student Development (IMSD) (T32 - Clinical Trial Not Allowed) |
93.859 |
PAR-21-025 |
| Diabetes Research Centers (P30 Clinical Trial Optional) |
93.847 |
RFA-DK-20-025 |
| Biological Testing Facility (X01 Clinical Trial Not Allowed) |
93.865 |
PAR-21-078 |
| Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) |
93.242, 93.313 |
RFA-MH-21-106 |
| Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional) |
93.853 |
PAR-21-056 |
| NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required) |
93.867 |
PAR-21-042 |
| Outstanding New Environmental Scientist (ONES) Award (R01 Clinical Trial Optional) |
93.113 |
RFA-ES-21-001 |
| NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-21-079 |
| Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) |
93.398 |
PAR-21-067 |
| NEI Collaborative Clinical Vision Research : Chair's Grant (UG1-Clinical Trial Required) |
93.867 |
PAR-21-041 |
| Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) |
93.242, 93.313 |
RFA-MH-21-105 |
| Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) |
93.398 |
PAR-21-066 |
| NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- Clinical Trial Required) |
93.867 |
PAR-21-043 |
Search Results 4001-4040 of 17927
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 [Next] |
